| Accession | SAMC1558046 |
|---|---|
| Accession in Other Database | GSA-Human: HRS122991 |
| Sample name | LH-2020133-088CF |
| Title | Blood from A chinese urothelithal carcinoma patient enrolled in the Chinese PLA General Hospital, Beijing, China |
| Sample type | Human sample |
| Organism | Homo sapiens |
| Description | A chinese urothelithal carcinoma patient enrolled in the Chinese PLA General Hospital, Beijing, China |
| Attributes | *This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA000491 in the GSA-Human system. |
| Release date | 2021-01-05 |
| BioProject Accession | PRJCA003945 |
| Submitter | Bo Yang (Jiaoshunchang301@126.com) |
| Organization | Chinese PLA General Hospital |
| Submission date | 2023-06-18 |
| Resource name | Description |
|---|---|
| GSA-Human (1) | - |
| HRA000491 (Controlled Access) | Urothelial carcinoma (UC) is the most common genitourinary malignancy in China. In this study, we studied the genomic features in Chinese UC patients and investigated the concordance of genetic alterations between serum circulating tumor-free DNA (ctDNA) and matched tumor tissue. A total of 112 UC patients were enrolled, and 31 of which were upper tract UC (UTUC) and 81 were UC of the bladder (UCB), respectively. Utilizing target next-generation sequencing, we analyzed genomic alterations of 92 selected genes. |